TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors.

Sylvie Rottey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.